{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:47:23Z","timestamp":1794836843076,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005753","name":"Royal Physiographic Society of Lund","doi-asserted-by":"publisher","award":["43037"],"award-info":[{"award-number":["43037"]}],"id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2021-0112"],"award-info":[{"award-number":["FO2021-0112"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006189","name":"Direkt\u00f6r Albert P\u00e5hlssons Stiftelse","doi-asserted-by":"publisher","award":["120482"],"award-info":[{"award-number":["120482"]}],"id":[{"id":"10.13039\/501100006189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","award":["20220654"],"award-info":[{"award-number":["20220654"]}],"id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","award":["20190782"],"award-info":[{"award-number":["20190782"]}],"id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","award":["F 2015\/2112"],"award-info":[{"award-number":["F 2015\/2112"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013081","name":"Augsburg University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006738","name":"Lunds University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001728","name":"STINT","doi-asserted-by":"publisher","award":["MG19-8469"],"award-info":[{"award-number":["MG19-8469"]}],"id":[{"id":"10.13039\/501100001728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopha.2023.114628","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:59:40Z","timestamp":1680501580000},"page":"114628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lung"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-1347","authenticated-orcid":false,"given":"Lotte","family":"Vanherle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-8831","authenticated-orcid":false,"given":"Frank","family":"Matthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska E.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-7213","authenticated-orcid":false,"given":"Anja","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4922","key":"10.1016\/j.biopha.2023.114628_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2023.114628_bib2","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S2213-2600(16)30047-9","article-title":"Pilot evaluation of ivacaftor for chronic bronchitis","volume":"4","author":"Solomon","year":"2016","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.biopha.2023.114628_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coph.2017.09.013","article-title":"The therapeutic potential of CFTR modulators for COPD and other airway diseases","volume":"34","author":"Solomon","year":"2017","journal-title":"Curr. Opin. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2023.114628_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101437","article-title":"Dysfunction in the cystic fibrosis transmembrane regulator in chronic obstructive pulmonary disease as a potential target for personalised medicine","volume":"9","author":"Carrasco-Hern\u00e1ndez","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.biopha.2023.114628_bib5","doi-asserted-by":"crossref","first-page":"a009746","DOI":"10.1101\/cshperspect.a009746","article-title":"The cystic fibrosis of exocrine pancreas","volume":"3","author":"Wilschanski","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"22","key":"10.1016\/j.biopha.2023.114628_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.047316","article-title":"Tumor necrosis factor-\u03b1-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure","volume":"125","author":"Meissner","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2023.114628_bib7","doi-asserted-by":"crossref","DOI":"10.1369\/jhc.2009.953455","article-title":"Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain","volume":"57","author":"Guo","year":"2009","journal-title":"J. Histochem Cytochem"},{"issue":"6 Pt 2","key":"10.1016\/j.biopha.2023.114628_bib8","article-title":"Both the wild type and a functional isoform of CFTR are expressed in kidney","author":"Morales","year":"1996","journal-title":"Am. J. Physiol. 270"},{"issue":"6","key":"10.1016\/j.biopha.2023.114628_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/lary.23278","article-title":"Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein","volume":"122","author":"Alexander","year":"2012","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.otohns.2010.05.021","article-title":"Hesperidin stimulates cystic fibrosis transmembrane conductance regulator-mediated chloride secretion and ciliary beat frequency in sinonasal epithelium","volume":"143","author":"Azbell","year":"2010","journal-title":"Otolaryngol. Head. Neck Surg."},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archotol.131.3.237","article-title":"Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation","volume":"131","author":"Wang","year":"2005","journal-title":"Arch. Otolaryngol. Neck Surg."},{"issue":"2","key":"10.1016\/j.biopha.2023.114628_bib12","doi-asserted-by":"crossref","DOI":"10.1096\/fj.11-192377","article-title":"Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration","volume":"26","author":"Clunes","year":"2012","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.biopha.2023.114628_bib13","doi-asserted-by":"crossref","DOI":"10.1096\/fj.14-268755","article-title":"Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection","volume":"29","author":"Londino","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2015.11.003","article-title":"Acquired cystic fibrosis transmembrane conductance regulator dysfunction in chronic bronchitis and other diseases of mucus clearance","volume":"37","author":"Raju","year":"2016","journal-title":"Clin. Chest Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001325","article-title":"A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system","volume":"7","author":"Bomberger","year":"2011","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.biopha.2023.114628_bib16","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.545137","article-title":"Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction","volume":"289","author":"Rasmussen","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2023.114628_bib17","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200508-1330OC","article-title":"Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers","volume":"173","author":"Cantin","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"8","key":"10.1016\/j.biopha.2023.114628_bib18","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00039.2013","article-title":"Cigarette smoke and CFTR: implications in the pathogenesis of COPD","volume":"305","author":"Rab","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2023.114628_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jacbts.2019.07.004","article-title":"CFTR therapeutics normalize cerebral perfusion deficits in mouse models of heart failure and subarachnoid hemorrhage","volume":"4","author":"Lidington","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.biopha.2023.114628_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104384","article-title":"Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator","volume":"86","author":"Vanherle","year":"2022","journal-title":"eBioMedicine"},{"issue":"2","key":"10.1016\/j.biopha.2023.114628_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/ijms23020866","article-title":"Therapeutic CFTR correction normalizes systemic and lung-specific S1P level alterations associated with heart failure","volume":"23","author":"Uhl","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114628_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928300","article-title":"Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation","volume":"13","author":"Uhl","year":"2022","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2023.114628_bib23","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.2014.274464","article-title":"The G551D CFTR chloride channel spurs the development of personalized medicine","volume":"592","author":"Fischer","year":"2014","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib24","first-page":"70","article-title":"Orphan drug pricing and costs: a case study of kalydeco and orkambi","volume":"15","author":"Hollis","year":"2019","journal-title":"Health Policy"},{"key":"10.1016\/j.biopha.2023.114628_bib25","doi-asserted-by":"crossref","unstructured":"H.N. \u00c1sgeirsd\u00f3ttir, S.J. Cohen, R.W.S. Jr., Object and place information processing by CA1 hippocampal neurons of C57BL\/6J mice, Journal of Neurophysiology 123(3) (2020) 1247\u20131264.","DOI":"10.1152\/jn.00278.2019"},{"issue":"17","key":"10.1016\/j.biopha.2023.114628_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2013.07.002","article-title":"The rodent hippocampus is essential for nonspatial object memory","volume":"23","author":"Cohen","year":"2013","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41514-021-00071-w","article-title":"Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia","volume":"7","author":"Don-Doncow","year":"2021","journal-title":"NPJ Aging Mech. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.114628_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001920","article-title":"Tumor necrosis factor-alpha underlies loss of cortical dendritic spine density in a mouse model of congestive heart failure","volume":"4","author":"Meissner","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.114628_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnana.2016.00038","article-title":"Golgi-cox staining step by step","volume":"10","author":"Zaqout","year":"2016","journal-title":"Front Neuroanat."},{"issue":"4","key":"10.1016\/j.biopha.2023.114628_bib30","first-page":"387","article-title":"Dendritic organization in the neurons of the visual and motor cortices of the cat","volume":"87","author":"Sholl","year":"1953","journal-title":"J. Anat."},{"issue":"22","key":"10.1016\/j.biopha.2023.114628_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.047316","article-title":"Tumor necrosis factor-alpha-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure","volume":"125","author":"Meissner","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2023.114628_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.111.039644","article-title":"Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-alpha-dependent activation of sphingosine-1-phosphate signaling","volume":"126","author":"Yang","year":"2012","journal-title":"Circulation"},{"issue":"44","key":"10.1016\/j.biopha.2023.114628_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2023.114628_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039809","article-title":"A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease","volume":"7","author":"Sloane","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2023.114628_bib35","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00404.2009","article-title":"Influence of cell background on pharmacological rescue of mutant CFTR","volume":"298","author":"Pedemonte","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1165\/rcmb.2016-0226OC","article-title":"The cystic fibrosis transmembrane conductance regulator potentiator ivacaftor augments mucociliary clearance abrogating cystic fibrosis transmembrane conductance regulator inhibition by cigarette smoke","volume":"56","author":"Raju","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-7-125","article-title":"Role of TNF\u03b1 in pulmonary pathophysiology","volume":"7","author":"Mukhopadhyay","year":"2006","journal-title":"Respir. Res."},{"issue":"6 Pt 1","key":"10.1016\/j.biopha.2023.114628_bib38","article-title":"Inflammatory cytokines in cystic fibrosis lungs","volume":"152","author":"Bonfield","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.114628_bib39","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.114628_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00318-2019","article-title":"Ivacaftor decreases monocyte sensitivity to interferon-\u03b3 in people with cystic fibrosis","volume":"6","author":"Hisert","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.biopha.2023.114628_bib41","unstructured":"D.o.H. Australian Government, Australian Public Assessment Report for Lumacaftor\/Ivacaftor, (2016)."},{"key":"10.1016\/j.biopha.2023.114628_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121859","article-title":"Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance","volume":"622","author":"Guan","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib43","doi-asserted-by":"crossref","first-page":"17066","DOI":"10.1038\/s41598-018-35151-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.2008-0170OC","article-title":"Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-\/- mice","volume":"40","author":"Bruscia","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114628_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/acsptsci.2c00007","article-title":"Ivacaftor alters macrophage and lymphocyte infiltration in the lungs following lipopolysaccharide exposure","volume":"5","author":"Harwood","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.114628_bib46","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcf.2022.03.012","article-title":"Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D","volume":"21","author":"Hoppe","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41232-017-0037-6","article-title":"The roles of RGMa-neogenin signaling in inflammation and angiogenesis","volume":"37","author":"Fujita","year":"2017","journal-title":"Inflamm. Regen."},{"issue":"6","key":"10.1016\/j.biopha.2023.114628_bib48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/CIRCGENETICS.113.000654","article-title":"Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome","volume":"7","author":"Kronenberg","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.164.3.1200","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting fas ligand expression1","volume":"164","author":"Delgado","year":"2000","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114628_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2003.tb03145.x","article-title":"PACAP in Immunity and Inflammation","volume":"992","author":"DELGADO","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.114628_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/qjmed\/hcv067","article-title":"CFTR regulates acute inflammatory responses in macrophages","volume":"108","author":"Gao","year":"2015","journal-title":"QJM Int. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.114628_bib52","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.0412188","article-title":"Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection","volume":"92","author":"Bonfield","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2023.114628_bib53","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ncb1456","article-title":"CFTR regulates phagosome acidification in macrophages and alters bactericidal activity","volume":"8","author":"Di","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00963-09","article-title":"Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae","volume":"78","author":"Phipps","year":"2010","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121200","article-title":"Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts","volume":"10","author":"Ni","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2023.114628_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial","volume":"2","author":"Boyle","year":"2014","journal-title":"Lancet Respir. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib57","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.114628_bib58","doi-asserted-by":"crossref","first-page":"L432","DOI":"10.1152\/ajplung.00461.2017","article-title":"Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa","volume":"314","author":"Barnaby","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"14","key":"10.1016\/j.biopha.2023.114628_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147606","article-title":"Anti-inflammatory influences of cystic fibrosis transmembrane conductance regulator drugs on lung inflammation in cystic fibrosis","volume":"22","author":"Harwood","year":"2021","journal-title":"Int J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:27:53Z","timestamp":1778542073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222300416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"alternative-id":["S075333222300416X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114628","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lung","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114628"}}